Please click here to view the flyer.
REGISTER HERE: https://attendee.gotowebinar.com/register/1104192650747595019
Join us in our discussion on Subgroup Analyses at 4pm (BST) on Thursday 24th October.
Our two presenters are Cynthia Huber from the Department of Medical Statistics, University Medical Centre Gottingen and Christoph Muysers and Bodo Kirsch from Bayer. The chair of the webinar is Anna Berglind from AstraZeneca.
(PSI) A comparison of subgroup identification methods in clinical drug development: Simulation study and regulatory considerations – Cynthia Huber, Norbert Benda and Tim Friede
(DIA) A Systematic Approach for Post Hoc Subgroup Analyses With Applications in Clinical Case Studies – Christoph Muysers et al.
The webinar is sponsored by Wiley who will make the PSI paper free to access for a few weeks before and after the webinar.
This course is aimed at clinical trial statisticians who are new to or with limited experience of machine learning. Attendees will learn about a range of topics in machine learning, including practical sessions in R.
This webinar will explore two different approaches to Correlates of Protection in vaccine development.
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
The event will open with an overview on drug development in women’s health from a clinician perspective. This talk is followed by talks about statistical challenges when planning IVF studies and analysing the menstrual cycles.
This webinar will provide an overview of surrogacy for licensing and reimbursement. In turn, the need of extensions of the SPIRIT and CONSORT statement will be defined and outlined, with case studies to support.
Lea Vaas will present how replacement of concurrent control animals by Virtual Control Groups (VCGs) in systemic toxicity studies may help in contributing to the 3R's principle of animal experimentation: Reduce, Refine, Replace.
We will share a brief overview of what Mobilise D is and why it is an important step stone in the development of digital biomarkers, and how Mobilise D outputs can be relevant for you.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
We have exciting new opportunities available for Study Statisticians, Support Statisticians and Exploratory Statisticians at various levels.
